Anthony Baxter

Pharmaceutical Science
Huntingdon Life Sciences
United States of America

Biography

Currently a holder of several non executive positions in life sciences companies Dr Baxter was CEO of deltaDOT Ltd, a proteomics genomics analysis platform company, founding CEO of Argenta, which he successfully merged with Etiologics, and was Chief Scientific Officer of Oxford Asymmetry International PLC. Most recently, he was CEO of Cyprotex PLC, which was sold to Evotec in December at a 75% premium to the share price. His early career included posts at Glaxo and Ciba Geigy Central Research (now Novartis).

Research Interest

Pharmaceutical Science

Global Experts from United States of America

Global Experts in Subject

Share This Profile

Recent Expert Updates

Matthew L Stone
pediatrics
University of Virginia Health System; Charlottesville, VA
United States of America
Dr. Matthew
pediatrics
University of Virginia Health System; Charlottesville, VA
United States of America
Dr. L Stone Matthew
pediatrics
University of Virginia Health System; Charlottesville, VA
United States of America
Dr. L Stone
pediatrics
University of Virginia Health System; Charlottesville, VA
United States of America
Dr. Matthew L Stone
pediatrics
University of Virginia Health System; Charlottesville, VA
United States of America
Dr. R Sameh
pediatrics
King Abdul Aziz University
United Arab Emirates
Dr. R Ismail,
pediatrics
King Abdul Aziz University
United Arab Emirates
Sameh R Ismail,
pediatrics
King Abdul Aziz University
United Arab Emirates
Dr. Sameh R Ismail,
pediatrics
King Abdul Aziz University
United Arab Emirates
Dr. William
pediatrics
Maimonides Medical Center
United States of America